drugset / Trial / NCT07086638

ROS-Scavenging Nanozyme Combined With Thermotherapy Alleviate Radiation Dermatitis in Patients With Head and Neck Cancer

NCT07086638 ↗

Recruiting 5 enrolled West China Hospital
NaSingle-groupOpen-labelTreatment

Summary

Severe radiation dermatitis remains a challenging complication in head and neck cancer with limited treatment options; this study aims to evaluate a novel Prussian blue-based nanozyme combined with near-infrared thermotherapy to promote effective healing of Grade III lesions.

Timeline

Start
2025-07-25
Primary completion
2026-05-30
Completion
2026-10-25

Drugs

EvaluationDrugModalityDoseRoute
Subject Photo-responsive nanozyme Unknown — —

Indications